文献检索，用中文搜 PubMed

1

Retracted: Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome.撤稿：人绒毛膜促性腺激素（hCG）对多囊卵巢综合征患者卵母细胞成熟影响机制的研究。

Comput Math Methods Med. 2023 Jun 28;2023:9768592. doi: 10.1155/2023/9768592. eCollection 2023.

2

Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome.多囊卵巢综合征患者人绒毛膜促性腺激素（hCG）对卵母细胞成熟影响机制的研究。

Comput Math Methods Med. 2022 Jul 14;2022:7933166. doi: 10.1155/2022/7933166. eCollection 2022.

3

Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone.使用不同剂量人绒毛膜促性腺激素触发最终卵母细胞成熟：一项在接受促性腺激素释放激素拮抗剂和重组促卵泡激素治疗的多囊卵巢综合征患者中的随机试点研究

Fertil Steril. 2007 Nov;88(5):1382-8. doi: 10.1016/j.fertnstert.2006.12.058. Epub 2007 Apr 18.

4

Human Chorionic Gonadotropin Priming Does Not Improve Pregnancy Outcomes of PCOS-IVM Cycles.人绒毛膜促性腺激素预处理不能改善 PCOS-IVM 周期的妊娠结局。

Front Endocrinol (Lausanne). 2020 Apr 30;11:279. doi: 10.3389/fendo.2020.00279. eCollection 2020.

5

Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.在体外成熟过程中暴露于人类绒毛膜促性腺激素并不能提高多囊卵巢综合征患者未成熟卵母细胞的成熟率和发育潜能。

Fertil Steril. 2008 Jan;89(1):98-103. doi: 10.1016/j.fertnstert.2007.02.021. Epub 2007 May 24.

6

Comparison of dual-trigger and human chorionic gonadotropin-only trigger among polycystic ovary syndrome couples who underwent controlled ovarian stimulation and intrauterine insemination: A retrospective cohort study.多囊卵巢综合征患者控制性卵巢刺激和宫腔内人工授精中双重触发与单纯人绒毛膜促性腺激素触发的比较：一项回顾性队列研究。

Medicine (Baltimore). 2023 Feb 3;102(5):e32867. doi: 10.1097/MD.0000000000032867.

7

Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome.多囊卵巢综合征未刺激女性未成熟卵母细胞取卵前注射人绒毛膜促性腺激素的前瞻性随机研究。

Hum Reprod. 2000 Jan;15(1):165-70. doi: 10.1093/humrep/15.1.165.

8

An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.一种改良的多囊卵巢综合征患者小卵泡卵丘-卵母细胞复合物的玻璃化方法可提高卵母细胞成熟度和胚胎产量。

Hum Reprod. 2017 Oct 1;32(10):2056-2068. doi: 10.1093/humrep/dex262.

9

The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.低剂量人绒毛膜促性腺激素对多囊卵巢综合征患者体外受精周期中卵泡反应和卵母细胞成熟的影响：一项疗效和安全性的随机临床试验。

Arch Gynecol Obstet. 2011 Dec;284(6):1431-8. doi: 10.1007/s00404-010-1827-0. Epub 2011 Jan 6.

10

Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome.多囊卵巢和多囊卵巢综合征患者非 hCG 启动的卵母细胞体外成熟治疗的临床结局。

Fertil Steril. 2011 Oct;96(4):860-4. doi: 10.1016/j.fertnstert.2011.07.1108. Epub 2011 Aug 24.

Suppr 超能文献

文献检索

文件翻译

深度研究

Suppr 超能文献

文献检索

文件翻译

深度研究

撤稿：人绒毛膜促性腺激素（hCG）对多囊卵巢综合征患者卵母细胞成熟影响机制的研究。

Retracted: Study on the Influencing Mechanism of Human Chorionic Gonadotropin (hCG) on Oocyte Maturation in Patients with Polycystic Ovary Syndrome.

作者信息

出版信息

相似文献